Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
. 2018 Aug 11;26:15–19. doi: 10.1016/j.nmni.2018.08.001

Genotypic characterization of Staphylococcus aureus isolated from a burn centre by using agr, spa and SCCmec typing methods

S Abbasian 1, NN Farahani 1, Z Mir 1, F Alinejad 2, M Haeili 3, M Dahmardehei 2, M Mirzaii 4, SS Khoramrooz 5, MJ Nasiri 6, D Darban-Sarokhalil 1,
PMCID: PMC6141672  PMID: 30245828

Abstract

Infections caused by Staphylococcus aureus remain a major global healthcare problem. We aimed to find the common lineages of S. aureus strains circulating in a burn hospital in Tehran. A total of 167 isolates of S. aureus obtained from patients, healthcare workers (HCWs) and environment in Shahid Motahari burn hospital were genotyped by using spa, agr and staphylococcal cassette chromosome mec (SCCmec) typing methods. Antimicrobial susceptibility testing was performed by using the disc diffusion method. The frequency of methicillin-resistant S. aureus (MRSA) was 64.7% (n = 108), with distribution frequencies among patient, HCW and surface isolates of 64.2% (n = 79), 50% (n = 7) and 73.3% (n = 22), respectively. SCCmec type III (75%, n = 81) was found to be the most frequent SCCmec type among MRSA isolates, followed by SCCmec type I (20.4%, n = 22) and SCCmec type IV (1.8%, n = 2). The remaining MRSA isolates (2.8%, n = 3) were nontypeable by this method. About 78.4% (n = 131), 10.2% (n = 17) and 4.8% (n = 8) of all isolates were characterized as agr types I, II and III, respectively, and the other isolates (6.6%) were nontypeable. spa types t030 and t037 constituted the first and second most predominant spa types found in 56.4% (n = 57) and 25.6% (n = 26) of isolates, respectively. We also report here a novel spa type, t16471. The most prevalent genotypes of the isolates found among patient, surface and HCW samples were SCCmec type III/t030, t037/agr type I. Continuous tracking of epidemic isolates and better hospital infection control policies are recommended to efficiently prevent the spread of bacteria to inpatients.

Keywords: agr typing, Iran, MRSA, SCCmec typing, spa typing

Introduction

Burns are among the devastating forms of trauma and burn wound infections are the most common complications after burn injury. Multidrug-resistant Staphylococcus aureus strains are considered to be one of the common Gram-positive early colonizers of burn wounds [1], [2]. Methicillin, a semisynthetic penicillin, first entered clinical use in 1960 for the treatment of infections caused by β-lactamase–producing staphylococci. However, only 1 year later, S. aureus strains that showed resistance to methicillin were reported from clinical infections. Since then, methicillin-resistant S. aureus (MRSA) strains have appeared in countries worldwide and continue to be one of the most common pathogens causing healthcare-associated infections (HAIs) [3]. HAIs caused by antibiotic-resistant bacteria are known to be associated with prolonged hospitalization as well as higher healthcare costs and mortality rates in burn patients, and according to a US Centers for Disease Control and Prevention report, 5% of all HAIs are caused by MRSA [4], [5]. The prevalence of MRSA varies from 20% to 90% in Iran [2]. MRSA is usually spread by direct contact with an infected wound or via contaminated hands. Previous studies have shown that about 33% and 2% of people carry S. aureus and MRSA in their nares, respectively [6].

MRSA usually carries molecular determinants that confer resistance to a wide range of antibiotics, and treatment of infections caused by these bacteria are challenging [1], [7]. A methicillin-susceptible S. aureus (MSSA) strain becomes MRSA by the acquisition of a genetic element called staphylococcal cassette chromosome mec (SCCmec), carrying the mecA gene, regulatory genes, recombinase genes and a variety of accessory genes. Molecular epidemiologic methods for the continuous surveillance of MRSA clones and dissemination of the strains can be used in order to control the infections [8], [9]. Over the past two decades, a variety of methods, such as pulsed-field gel electrophoresis, multilocus enzyme electrophoresis, multilocus sequence typing, accessory gene regulator (agr) typing and spa typing, have been used for genotypic characterization of MRSA strains and other bacteria [10]. Previous studies in Iran have reported SCCmec type III/to30, t037 as the most common genotypes among MRSA isolates [2]. As common typing methods, pulsed-field gel electrophoresis and multilocus sequence typing are considered to be labor-intensive and expensive; instead, other techniques such as spa, agr and SCCmec typing methods could be used for reliable and accurate typing of MRSA [11].

In the present study, we used a combination of different techniques including spa, agr and SCCmec typing to determine the common types of S. aureus strains circulating in one burn hospital in Tehran, Iran.

Materials and methods

Bacterial isolates

A total of 405 clinical and nonclinical samples were obtained from patients (pus and blood), nostrils of HCWs (physicians, nurses and service employees) and inanimate surfaces (Computer mice and keyboards, beds, chairs, medical trolleys, phone receivers, faucet handles, door handles, elevator buttons, toilet flush handles) from different wards (emergency, men, women, children and intensive care unit) in the Shahid Motahari burn hospital in Tehran from 2015 to 2016. Duplicate isolates from the same patient were not included in the study. The isolates were identified to the species level using standard biochemical tests including Gram staining, catalase, tube coagulase and DNase tests as well as mannitol fermentation. All S. aureus isolates were confirmed by PCR for the presence of the nucA gene [10].

Antimicrobial susceptibility testing

Antibiotic susceptibility testing was performed by using the disc diffusion method and in accordance with the Clinical and Laboratory Standards Institute guidelines for the following antibiotics: nitrofurantoin (300μg), gentamicin (10 μg), mupirocin (20 μg), rifampicin (5 μg), norfloxacin (10 μg), tigecycline (15 μg), ampicillin (10 μg), trimethoprim/sulfamethoxazole (25 μg), chloramphenicol (30 μg), erythromycin (15 μg), clindamycin (2 μg), tetracycline (30 μg), penicillin (10 U), linezolid (30 μg), quinupristin/dalfopristin (15 μg) and imipenem (10 μg) (Mast, Merseyside, UK). Screening for the MRSA isolates was performed using cefoxitin (30 μg) discs on Müller-Hinton agar plates [12].

DNA extraction and identification of MRSA isolates

DNA extraction was performed by using the boiling method as described previously [13]. All phenotypically identified methicillin-resistant isolates were confirmed by PCR for the presence of the mecA gene.

SCCmec typing

A multiplex PCR with four primer pairs was performed to identify the five main known SCCmec types [14]. PCR was performed in a final volume of 25 μL containing 0.5 μM of each primer. The PCR protocol consisted of an initial denaturation step at 94°C for 4 minutes, then 30 amplification cycles at 94°C for 30 seconds, at 55°C for 30 seconds and at 72°C for 1 minute, followed by a final extension step at 72°C for 5 minutes. Amplified products were analysed by electrophoresis on 1% agarose gel containing safe stain.

spa typing

spa typing was performed for MRSA isolates as described by Harmsen et al. [15]. The amplified products were subjected to DNA sequencing by Bioneer (Seoul, South Korea). The obtained sequences were edited by Chromas 1.45 software (Technelysium, Tewantin, Australia; http://technelysium.com.au/wp/chromaspro/). The guidelines from the Ridom SpaServer database (http://spaserver.ridom.de/) were used to assign the edited sequences to particular spa types.

agr typing

The agr types of all S. aureus isolates (MSSA and MRSA) were determined by the PCR method as described by Shopsin et al. [16].

Results

A total of 167 S. aureus strains were obtained in this study, of which 108 (64.7%) were found to be MRSA. The distribution of MRSA isolates among patients, HCWs and surfaces were 64.2% (n = 79), 50% (n = 7) and 73.3% (n = 22), respectively (Table 1). According to antibiotic susceptibility testing results, high rate of resistance to antibiotics such as cefoxitin (99%, n = 107), penicillin (96%, n = 104), norfloxacin (87%, n = 94), gentamicin (86%, n = 93), ampicillin (85%, n = 92), mupirocin and erythromycin (81%, n = 87), clindamycin (75%, n = 81) and rifampicin (65%, n = 70) was observed among MRSA strains. No resistance was observed for linezolid or tigecycline. The most frequent SCCmec type among 108 MRSA isolates was SCCmec type III (75%; n = 81), followed by type I (20.4%; n = 22) and type IV (1.8%; n = 2). The rest of the MRSA isolates (2.8%; n = 3) were nontypeable by this method. Also, by using the agr typing method, 78.4% (n = 131), 10.2% (n = 17) and 4.8% (n = 8) of isolates belonged to agr type I, II and III, respectively, and 6.6% of isolates (n = 11) were nontypeable. The results of SCCmec and agr typing are presented in Table 2, Table 3. spa types t030 and t037 were the first and second most predominant spa types in all patient, HCW and surface isolates, being found in 56.4% (n = 57) and 25.6% (n = 26) of isolates, respectively. Also, spa type t16471 was reported for the first time in the world in this study (Table 4). Distribution of molecular types and different resistant patterns in 101 MRSA isolates are shown in Table 4 (seven isolates were not typed by spa typing).

Table 1.

Frequency of MRSA and MSSA in patients, HCWs and surfaces in Shahid Motahari Hospital

Characteristic No. of samples MRSA MSSA Total
Patients 175 79 (64.2) 44 (35.8) 123 (100)
HCWs 88 7 (50) 7 (50) 14 (100)
Surfaces 142 22 (73.3) 8 (26.7) 30 (100)
Total 405 108 (64.7) 59 (35.3) 167 (100)

Data are presented as n (%).

HCW, healthcare worker; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.

Table 2.

Results of SCCmec typing among MRSA isolates

SCCmec type Patient HCW Surface Total
I 16 (14.8) 0 6 (5.6) 22 (20.4)
III 58 (53.7) 7 (6.5) 16 (14.8) 81 (75)
IV 2 (1.8) 0 0 2 (1.8)
Nontypeable 3 (2.8) 0 0 3 (2.8)
Total 79 (73.1) 7 (6.5) 22 (20.4) 108 (100)

Data are presented as n (%).

HCW, healthcare worker; MRSA, methicillin-resistant Staphylococcus aureus.

Table 3.

Genotyping of Staphylococcus aureus isolates by agr typing method

agr type Patient HCW Surface Total
I 94 (56.3) 13 (7.8) 24 (14.3) 131 (78.4)
II 11 (6.6) 2 (1.2) 4 (2.4) 17 (10.2)
III 8 (4.8) 0 0 8 (4.8)
IV 0 0 0 0
Negative 10 (6) 0 1 (0.6) 11 (6.6)
Total (%) 123 (73.7) 15 (9) 29 (17.3) 167 (100)

Data are presented as n (%).

HCW, healthcare worker.

Table 4.

Distribution of molecular types and different antibiotic resistant patterns in 101 MRSA isolates

spa type (N; %) No. patients No. HCWs No. surfaces SCCmec type agr type Resistance profile No. isolates
t030 (57; 56.4) 40 5 12 III, I I GM, MUP, RP, E, CD, T, IM, PG, NOR 48
NOR 2
NOR, SXT, PG 7
t037 (26; 25.6) 23 1 2 III, I I GM, NOR, SXT, CD, E, PG, IM 16
RP, MUP, GM, PG 4
PG, IM, T, CD, E 6
t046 (3; 3) 3 0 0 I I E, CD, T, PG, IM, GM, MUP, RP, NOR 3
t4864 (2; 2) 2 0 0 III II IM, PG, SXT, NOR, E, T, GM 2
t091 (2; 2) 2 0 0 NT, III II, I E, CD, T, PG, GM, MUP, SXT 2
t789 (2; 2) 2 0 0 NT, I III C, PG, CD, E 2
t459 (1; 1), t16471 (1; 1) 1, 0 0, 1 0, 0 I, III I GM, MUP, RP, NOR, E, CD, T, PG, IM 2
t363 (1; 1) 1 0 0 IV I MUP, E, PG, IM 1
t3802 (1; 1), t304 (1; 1) 1, 1 0, 0 0, 0 NT, I I PG 2
t937 (1; 1) 1 0 0 I II PG, IM 1
t230 (1; 1) 1 0 0 IV I MUP, PG, IM 1
t3132 (1; 1), t701 (1; 1) 0, 1 0, 0 1, 0 I, III II, I GM, MUP, NOR, E, CD, T, PG, IM 2

C, chloramphenicol; CD, clindamycin; E, erythromycin; GM, gentamycin; IM, imipenem; MRSA, methicillin-resistant Staphylococcus aureus; MUP, mupirocin; NOR, norfloxacin; NT, nontypeable; PG, penicillin; RP, rifampicin; SXT, trimethoprim/sulfamethoxazole; T, tetracycline.

Discussion

Because of the damage to the first mechanical barrier of the skin, burn patients are more prone to be colonized by different microorganisms. Sepsis is the major complication in burns and is associated with a high rate of mortality in burn patients [3]. Among different infection causing organisms, S. aureus and notably MRSA, is the major cause of HAIs as well as infections acquired from the community [17]. Different studies in Iran have shown an increase in the prevalence of MRSA in the country [18]. We found the prevalence of MRSA to be 64.7%, which is comparable to the results obtained by Namvar et al. [18] (65%) and Emaneini et al. (63.6%) [19]. This rate was higher than that reported by Darban-Sarokhalil et al. [2] (35%) and less than that of Song et al. [20] (98%). These discrepancies in the prevalence of MRSA among various studies might be due to the diverse antibiotic use patterns, different infection control policies and lack of supervision on antibiotic use in different centres. In this study, MRSA strains exhibited high rates of resistance to several antibiotics of different classes, notably mupirocin, which is the antibiotic of choice for the treatment of nasally carried staphylococcal infections.

S. aureus (MRSA) was found with high frequency in the hospital environment on different surfaces which can colonize the nares and hands of HCWs and therefore can be considered as an important source of dissemination to inpatients [6], [21]. Nowadays typing methods are considered as important tools to assess the prevalence and transmission origin of HAIs [22]. In this study, we used three typing methods (SCCmec, spa and agr typing) to find the common lineages of S. aureus strains circulating in one burn hospital in Tehran. While SCCmec types I, II and III are known to be found among the hospital-acquired clones (HA-MRSA), types IV and V are mostly considered to be community acquired [23], [24]. In this study, SCCmec types III and I were the most prevalent SCCmec types among MRSA isolates (75% and 20.4%, respectively). It can be concluded from this prevalence that the patients we studied might have acquired the infection from the hospital environment and/or HCWs as SCCmec type III, is related to HA-MRSA isolates. In previous studies from Iran performed by Fatholahzadeh et al. [25], Parhizgari et al. [22], Bayat et al. [26] and Namvar et al. [18], SCCmec type III was found among 98%, 97.5%, 82% and 56.8% of MRSA strains, respectively. Similarly, Chen et al. [27] and Rodrigues et al. [28] reported SCCmec type III to be the dominant type among colonizers of burn patients.

In this study, 15 different spa types were found, among which t030 (56.4%) and t037 (25.6%) were the predominant types. These results are in agreement with other studies from Iran and other Asian countries [26]. In a study carried out in South Africa, t037 was reported as one of the most dominant spa types. However, Emaneini et al. [29] reported types other than t030 and t037 as the dominant spa types. These discrepancies in prevalence among different studies may be attributed to differences in the type of sample or even the time of sampling and geographical areas. It seems that t037 has been replaced by t030 spa type in Iran's hospitals [26], [30]. In agreement with our study, several other studies have indicated that t030 and t037 types most commonly belonged to the SCCmec type III and were classified as HA-MRSA. Also, for the first time we found spa type t16471, which had not been reported to date in the world in an MRSA strain that had colonized the nose of a HCW. These findings raise serious concerns about the possible spread of MRSA from the hospital environment and HCWs to inpatients in Tehran's hospitals.

One of the crucial regulatory components of S. aureus involved in controlling the expression of bacterial virulence factors is accessory gene regulator (agr). So far, four agr types (I, II, III and IV) have been identified among S. aureus strains [31]. In our study, among the 167 S. aureus isolates, the predominant agr type was type I, with a frequency of 78.4%. This result is consistent with that of studies performed by van Leeuwen et al. [31] (71%), Peerayeh et al. [32] (55.1%) and Indrawattana et al. [33] (58.7%), who reported agr type I to be the most frequent agr type among S. aureus isolates. The prevalence of agr type I in our study was more than that reported by Shopsin et al. [16] in America (30.8%) and Ayed et al. [34] in Tunisia (15%). These dissimilarities may be related to the differences in patient samples as well as in geographic location. Also, because infection control policies might be periodically changing in a healthcare setting, various isolate types might be found during different periods of sample collection.

In summary, we used three different typing methods in order to find the most common lineages of S. aureus (MSSA and MRSA) circulating in the hospital and the origin of their spread to patients. According to SCCmec typing results, we found that MRSA isolated from patients, HCWs and environmental surfaces had the same genotype. The most prevalent genotypic background of the isolates was SCCmec type III/t030, t037/agr type I, which was found in high frequency in patient, surface and HCW isolates. Therefore, better hospital infection control policies as well as continuous epidemiologic surveillance studies are highly recommended to efficiently prevent the spread of bacteria to inpatients.

Acknowledgement

Supported in part by grant 26563-30-04-94 from the Deputy of Research and Technology, Iran University of Medical Sciences.

Conflict of interest

None declared.

References

  • 1.Murray P.R., Rosenthal K.S., Pfaller M.A. 6th ed. Mosby; Philadelphia, PA: 2009. Medical microbiology. [Google Scholar]
  • 2.Darban-Sarokhalil D., Khoramrooz S.S., Marashifard M., Hosseini S.A.A.M., Parhizgari N., Yazdanpanah M. Molecular characterization of Staphylococcus aureus isolates from southwest of Iran using spa and SCCmec typing methods. Microb Pathog. 2016;98:88–92. doi: 10.1016/j.micpath.2016.07.003. [DOI] [PubMed] [Google Scholar]
  • 3.Murray P.R., Baron E.J., Jorgensen J.H., Landry M.L., Pfaller M.A. 9th ed. ASM Press; Washington, DC: 2007. Manual of clinical microbiology. [Google Scholar]
  • 4.Garau J., Bouza E., Chastre J., Gudiol F., Harbarth S. Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect. 2009;15:125–136. doi: 10.1111/j.1469-0691.2009.02701.x. [DOI] [PubMed] [Google Scholar]
  • 5.US Department for Health and Human Services; Centers for Disease Control and Prevention . 23 April 2013. Antibiotic resistance threats in the United States, 2013.https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf Available at: [Google Scholar]
  • 6.Mayhall C.G. Lippincott Williams & Wilkins; Philadelphia, PA: 2012. Hospital epidemiology and infection control. [Google Scholar]
  • 7.Goldrick B. First reported case of VRSA in the United States: an alarming development in microbial resistance. Am J Nurs. 2002;102:17. doi: 10.1097/00000446-200211000-00015. [DOI] [PubMed] [Google Scholar]
  • 8.Van Belkum A. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains: state of affairs and tomorrow’s possibilities. Microb Drug Resist. 2000;6:173–188. doi: 10.1089/mdr.2000.6.173. [DOI] [PubMed] [Google Scholar]
  • 9.Andrei A., Zervos M.J. The application of molecular techniques to the study of hospital infection. Arch Pathol Lab Med. 2006;130:662–668. doi: 10.5858/2006-130-662-TAOMTT. [DOI] [PubMed] [Google Scholar]
  • 10.Sahebekhtiari N., Nochi Z., Eslampour M., Dabiri H., Bolfion M., Taherikalani M. Characterization of Staphylococcus aureus strains isolated from raw milk of bovine subclinical mastitis in Tehran and Mashhad. Acta Microbiol Immunol Hung. 2011;58:113–121. doi: 10.1556/AMicr.58.2011.2.4. [DOI] [PubMed] [Google Scholar]
  • 11.Shopsin B., Kreiswirth B.N. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2001;7:323. doi: 10.3201/eid0702.010236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Clinical and Laboratory Standards Institute . Clinical and Laboratory Standards Institute; Wayne, PA: 2015. Performance standards for antimicrobial susceptibility testing. [Google Scholar]
  • 13.Dashti A.A., Jadaon M.M., Abdulsamad A.M., Dashti H.M. Heat treatment of bacteria: a simple method of DNA extraction for molecular techniques. Kuwait Med J. 2009;41:117–122. [Google Scholar]
  • 14.Boye K., Bartels M.D., Andersen I.S., Møller J.A., Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I–V. Clin Microbiol Infect. 2007;13:725–727. doi: 10.1111/j.1469-0691.2007.01720.x. [DOI] [PubMed] [Google Scholar]
  • 15.Harmsen D., Claus H., Witte W., Rothgänger J., Claus H., Turnwald D. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41:5442–5448. doi: 10.1128/JCM.41.12.5442-5448.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shopsin B., Mathema B., Alcabes P., Said-Salim B., Lina G., Matsuka A. Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J Clin Microbiol. 2003;41:456–459. doi: 10.1128/JCM.41.1.456-459.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Still J., Law E., Friedman B., Fuhrman S., Newton T. Vancomycin-resistant organisms on a burn unit. South Med J. 2001;94:810–812. [PubMed] [Google Scholar]
  • 18.Namvar A.E., Afshar M., Asghari B., Lari A.R. Characterisation of SCCmec elements in methicillin-resistant Staphylococcus aureus isolated from burn patients. Burns. 2014;40:708–712. doi: 10.1016/j.burns.2013.09.010. [DOI] [PubMed] [Google Scholar]
  • 19.Emaneini M., Bigverdi R., Kalantar D., Soroush S., Jabalameli F., Khoshgnab B.N. Distribution of genes encoding tetracycline resistance and aminoglycoside modifying enzymes in Staphylococcus aureus strains isolated from a burn center. Ann Burns Fire Disasters. 2013;26:76–80. [PMC free article] [PubMed] [Google Scholar]
  • 20.Song W., Lee K.M., Kang H.J., Shin D.H., Kim D.K. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001;27:136–139. doi: 10.1016/s0305-4179(00)00086-3. [DOI] [PubMed] [Google Scholar]
  • 21.Wertheim H.F., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762. doi: 10.1016/S1473-3099(05)70295-4. [DOI] [PubMed] [Google Scholar]
  • 22.Parhizgari N., Khoramrooz S.S., Hosseini M., Asghar S.A., Marashifard M., Yazdanpanah M. High frequency of multidrug-resistant Staphylococcus aureus with SCCmec type III and spa types t037 and t631 isolated from burn patients in southwest of Iran. APMIS. 2016;124:221–228. doi: 10.1111/apm.12493. [DOI] [PubMed] [Google Scholar]
  • 23.Bigelow N., Ng L.K., Robson H., Dillon J. Strategies for molecular characterisation of methicillin- and gentamicin-resistant Staphylococcus aureus in a Canadian nosocomial outbreak. J Med Microbiol. 1989;30:51–58. doi: 10.1099/00222615-30-1-51. [DOI] [PubMed] [Google Scholar]
  • 24.Ito T., Okuma K., Ma X.X., Yuzawa H., Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat. 2003;6:41–52. doi: 10.1016/s1368-7646(03)00003-7. [DOI] [PubMed] [Google Scholar]
  • 25.Fatholahzadeh B., Emaneini M., Gilbert G., Udo E., Aligholi M., Modarressi M.H. Staphylococcal cassette chromosome mec (SCCmec) analysis and antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolates in Tehran, Iran. Microb Drug Resist. 2008;14:217–220. doi: 10.1089/mdr.2008.0822. [DOI] [PubMed] [Google Scholar]
  • 26.Bayat B., Zade M.H., Mansouri S., Kalantar E., Kabir K., Zahmatkesh E. High frequency of methicillin-resistant Staphylococcus aureus (MRSA) with SCCmec type III and spa type t030 in Karaj’s teaching hospitals, Iran. Acta Microbiol Immunol Hung. 2017;1:1–11. doi: 10.1556/030.64.2017.020. [DOI] [PubMed] [Google Scholar]
  • 27.Chen X., Yang H.H., Huangfu Y.C., Wang W.K., Liu Y., Ni Y.X. Molecular epidemiologic analysis of Staphylococcus aureus isolated from four burn centers. Burns. 2012;38:738–742. doi: 10.1016/j.burns.2011.12.023. [DOI] [PubMed] [Google Scholar]
  • 28.Rodrigues M.V.P., Fortaleza C.M.C.B., Riboli D.F.M., Rocha R.S., Rocha C., de Souza MdLR. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a burn unit from Brazil. Burns. 2013;39:1242–1249. doi: 10.1016/j.burns.2013.02.006. [DOI] [PubMed] [Google Scholar]
  • 29.Emaneini M., Khoramrooz S.S., Taherikalani M., Jabalameli F., Aligholi M. Molecular characterization of Staphylococcus aureus isolated from children with adenoid hypertrophy: emergence of new spa types t7685 and t7692. Int J Pediatr Otorhinolaryngol. 2011;75:1446–1449. doi: 10.1016/j.ijporl.2011.08.013. [DOI] [PubMed] [Google Scholar]
  • 30.Chen H., Liu Y., Jiang X., Chen M., Wang H. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother. 2010;54:1842–1847. doi: 10.1128/AAC.01563-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.van Leeuwen W., van Nieuwenhuizen W., Gijzen C., Verbrugh H., van Belkum A. Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide. J Bacteriol. 2000;182:5721–5729. doi: 10.1128/jb.182.20.5721-5729.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Peerayeh S.N., Azimian A., Nejad Q.B., Kashi M. Prevalence of agr specificity groups among Staphylococcus aureus isolates from university hospitals in Tehran. Lab Med. 2015;40:27–29. [Google Scholar]
  • 33.Indrawattana N., Sungkhachat O., Sookrung N., Chongsa-Nguan M., Tungtrongchitr A., Voravuthikunchai S. Staphylococcus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm. Biomed Res Int. 2013;2013:314654. doi: 10.1155/2013/314654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ayed S.B., Boubaker I.B.B., Samir E., Redjeb S.B. Prevalence of agr specificity groups among methicilin resistant Staphylococcus aureus circulating at Charles Nicolle hospital of Tunis. Pathol Biol. 2006;54:435–438. doi: 10.1016/j.patbio.2006.07.010. [DOI] [PubMed] [Google Scholar]

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES